Skip to main content

Fundraising

Raise from the right source at the right stage — or the capital itself becomes a constraint.

The Staging Question

Fundraising strategy is sequencing strategy. The capital you take defines the ceiling, the timeline, and the accountability you accept. Taking venture capital before product-market fit often creates pressure that kills the search for fit.

Funding source by stage:

StageSourceWhat you give upWhat you get
IdeaFounder savings, grantsNothing structuralOptionality
MVPFriends and family, angels5-15% equitySpeed + belief
TractionSeed VCs, syndicates15-25% equity + board seatScale capital
GrowthSeries A+Board control, liquidation prefsGrowth capital
TokenizedToken sale, DAOToken governanceCommunity alignment

The dilution trap: Raising too much too early at too high a valuation creates expectations that constrain the next round. A $5M seed at $20M post creates a bar that a Series A needs to clear to make the economics work for earlier investors.

What VCs are actually buying: Not the idea — the team's ability to navigate uncertainty and produce returns at fund scale. A $100M fund needs $1B+ outcomes to return the fund. That shapes what they fund and how hard they push.

Non-dilutive options: Revenue-based financing, government grants, and revenue traction that funds growth internally are all structurally preferable to equity — if the business can generate them. The best fundraise is one you don't need.

Context

Questions

At what revenue level does a business earn the right to raise external capital on its own terms — rather than accepting investor terms out of necessity?

  • Which funding source — angels, grants, or early customers — produces the least distortion to product direction during the search for product-market fit?
  • How does token-based fundraising change the relationship between capital and governance — and what new failure modes does it introduce compared to equity?
  • What does a startup lose when it raises capital before it understands its customer?